BIIB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Biogen (BIIB) Earnings Date & Reports

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

BIIB is expected to report earnings to rise 4.07% to $3.58 per share on April 23

Q1'25

Est.

$3.58

Q4'24

Beat

by $0.03

Q3'24

Beat

by $0.31

Q2'24

Beat

by $1.27

Q1'24

Beat

by $0.24

The last earnings report on February 12 showed earnings per share of $3.44, beating the estimate of $3.41. With 2.44M shares outstanding, the current market capitalization sits at 31.34B.

View a ticker or compare two or three

Compare

BIIB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BIIB
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BIIB (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

Biotechnology

Address

225 Binney Street

Phone

+1 617 679-2000

Employees

7570

Web

https://www.biogen.com